{"podcast":{"title":"Eyewire News: The Podcast","slug":"eyewire-news-the-podcast-7055536","podcast_index_feed_id":7055536,"rss_url":"https://feeds.megaphone.fm/eyewire","website_url":null,"image_url":"https://megaphone.imgix.net/podcasts/76175cb8-6a11-11ef-a54a-87470a073a58/image/a6563563ccdf4f408d6aad7c3182e268.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"Bryn Mawr Communications (BMC)","episode_count":92,"summary":"Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536"},"episode":{"title":"Update on Reproxalap PDUFA Timing","slug":"update-on-reproxalap-pdufa-timing","published_at":"2025-12-17T20:44:00+00:00","page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing","show_page_url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536","url":"https://traffic.megaphone.fm/BMCL3681770584.mp3","audio_url":"https://traffic.megaphone.fm/BMCL3681770584.mp3","summary":"Aldeyra provides an update on the timing of its dry eye disease treatment candidate reproxalap; Ocular Therapeutix pursues an accelerated NDA pathway for wet AMD therapy Axpaxli; and companies with late-stage drug candidates announce FDA submission plans. Learn more about your ad choices. Visit megaphone.fm/adchoices","meta_description":"Aldeyra provides an update on the timing of its dry eye disease treatment candidate reproxalap; Ocular Therapeutix pursues an accelerated NDA pathway for…","key_points":[],"chapters":[],"topics":[],"duration_seconds":531,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/update-on-reproxalap-pdufa-timing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}